Literature DB >> 5726388

Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78).

C H Kempe, V Fulginiti, M Minamitani, H Shinefield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5726388

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  18 in total

1.  Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain.

Authors:  F Scheiflinger; F G Falkner; F Dorner
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.

Authors:  T D Lockey; K S Slobod; T E Caver; S D'Costa; R J Owens; H M McClure; R W Compans; J L Hurwitz
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody.

Authors:  J D Rosenthal; K Hayashi; A L Notkins
Journal:  Appl Microbiol       Date:  1973-04

Review 4.  Immunization today--a review.

Authors:  M I Marks; M Brazeau; R M Shapera
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

5.  Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.

Authors:  Minoru Kidokoro; Masato Tashiro; Hisatoshi Shida
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

6.  Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

Authors:  Igor M Belyakov; Patricia Earl; Amiran Dzutsev; Vladimir A Kuznetsov; Michael Lemon; Linda S Wyatt; James T Snyder; Jeffrey D Ahlers; Genoveffa Franchini; Bernard Moss; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

7.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

8.  Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.

Authors:  B T Ober; P Brühl; M Schmidt; V Wieser; W Gritschenberger; S Coulibaly; H Savidis-Dacho; M Gerencer; F G Falkner
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.

Authors:  R C Dunlap; L F Barker
Journal:  Arch Gesamte Virusforsch       Date:  1973

10.  Virion polypeptides of poxviruses.

Authors:  M Arita; I Tagaya
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.